Owner Emergent Product Development Seattle, LLC

Inventors Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha

Agent Griffith Hack

Pub. Number AU-A-2012227176

Parent 2008200400

Filing date 7 September 2012

Wipo publication date 4 October 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 Medicinal preparations containing peptides

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 3/10 Drugs for disorders of the metabolism

A61P 5/14 Drugs for disorders of the endocrine system

A61P 21/04 Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

A61P 37/06 Drugs for immunological or allergic disorders

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C07K 19/00 Hybrid peptides

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione